What does CUSIP 03152W109 represent in this 13F holders report?

CUSIP 03152W109 is the security identifier for FOLD - AMICUS THERAPEUTICS, INC. - Common Stock used to aggregate holder disclosures.

How many institutions held FOLD - AMICUS THERAPEUTICS, INC. - Common Stock in Q1 2018?

198 institutional investors reported FOLD - AMICUS THERAPEUTICS, INC. - Common Stock for Q1 2018. Use the holders table for investor-level position and value details.

AMICUS THERAPEUTICS, INC. - Common Stock (FOLD)

CUSIP: 03152W109

Q1 2018 13F Holders as of 31 Mar 2018

Type / Class: Equity / Common Stock
Shares outstanding: 312,579,912
Total 13F shares: 224,632,187
Share change: +18,856,275
Total reported value: $3,376,722,825
Put/Call ratio: 63%
Price per share: $15.04
Number of holders: 198
Value change: +$286,532,653
Number of buys: 120
Number of sells: 72

Quarterly Holders Quick Answers

What is CUSIP 03152W109?
CUSIP 03152W109 identifies FOLD - AMICUS THERAPEUTICS, INC. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q2 2018
Previous quarter: Q4 2017

Recent filing periods for CUSIP 03152W109:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of FOLD - AMICUS THERAPEUTICS, INC. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
FMR LLC	13F	Company	5.8%	17,983,531	$258,782,000	—	31 Dec 2017	13F
PERCEPTIVE ADVISORS LLC	13F	Company	5.7%	17,888,597	$257,417,000	—	31 Dec 2017	13F
BlackRock Finance, Inc.	13F	Company	4.4%	13,712,097	$197,317,000	—	31 Dec 2017	13F
VANGUARD GROUP INC	13F	Company	4.4%	13,634,785	$196,204,000	—	31 Dec 2017	13F
Redmile Group, LLC	13F	Company	3.2%	10,025,770	$144,271,000	—	31 Dec 2017	13F
JENNISON ASSOCIATES LLC	13F	Company	3.1%	9,702,113	$139,613,000	—	31 Dec 2017	13F
PRICE T ROWE ASSOCIATES INC /MD/	13F	Company	2.9%	9,063,311	$130,421,000	—	31 Dec 2017	13F
JANUS HENDERSON GROUP PLC	13F	Company	2.5%	7,916,701	$113,921,000	—	31 Dec 2017	13F
STATE STREET CORP	13F	Company	2.5%	7,838,452	$112,794,000	—	31 Dec 2017	13F
Avoro Capital Advisors LLC	13F	Company	2.3%	7,263,122	$104,516,000	—	31 Dec 2017	13F
Palo Alto Investors LP	13F	Company	1.9%	6,006,022	$86,427,000	—	31 Dec 2017	13F
ORBIMED ADVISORS LLC	13F	Company	1.8%	5,572,500	$80,188,000	—	31 Dec 2017	13F
WELLINGTON MANAGEMENT GROUP LLP	13F	Company	1.8%	5,533,131	$79,621,000	—	31 Dec 2017	13F
MORGAN STANLEY	13F	Company	1.5%	4,610,187	$66,340,000	—	31 Dec 2017	13F
FRANKLIN RESOURCES INC	13F	Company	1.2%	3,718,899	$53,515,000	—	31 Dec 2017	13F
CITADEL ADVISORS LLC	13F	Company	1.2%	3,670,668	$52,821,000	—	31 Dec 2017	13F
Tourbillon Capital Partners, L.P.	13F	Company	1.1%	3,288,300	$47,319,000	—	31 Dec 2017	13F
Point72 Asset Management, L.P.	13F	Company	0.92%	2,870,100	$41,301,000	—	31 Dec 2017	13F
SECTORAL ASSET MANAGEMENT INC	13F	Company	0.91%	2,850,769	$41,023,000	—	31 Dec 2017	13F
FARALLON CAPITAL MANAGEMENT LLC	13F	Company	0.89%	2,781,000	$40,019,000	—	31 Dec 2017	13F
EAGLE ASSET MANAGEMENT INC	13F	Company	0.85%	2,661,511	$38,558,000	—	31 Dec 2017	13F
VICTORY CAPITAL MANAGEMENT INC	13F	Company	0.85%	2,644,924	$38,061,000	—	31 Dec 2017	13F
FRAZIER MANAGEMENT LLC	13F	Company	0.83%	2,600,014	$37,414,000	—	31 Dec 2017	13F
D. E. Shaw & Co., Inc.	13F	Company	0.79%	2,456,213	$35,345,000	—	31 Dec 2017	13F
DEUTSCHE BANK AG\	13F	Company	0.63%	1,975,120	$28,420,000	—	31 Dec 2017	13F
NORTHERN TRUST CORP	13F	Company	0.63%	1,971,488	$28,369,000	—	31 Dec 2017	13F
CARILLON TOWER ADVISERS, INC.	13F	Company	0.59%	1,859,320	$26,756,000	—	31 Dec 2017	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.5%	1,566,261	$22,538,000	—	31 Dec 2017	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.5%	1,563,032	$22,492,000	—	31 Dec 2017	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.42%	1,318,573	$18,974,000	—	31 Dec 2017	13F
NORGES BANK	13F	Company	0.4%	1,247,933	$17,958,000	—	31 Dec 2017	13F
VOYA INVESTMENT MANAGEMENT LLC	13F	Company	0.39%	1,215,239	$17,487,000	—	31 Dec 2017	13F
SPHERA FUNDS MANAGEMENT LTD.	13F	Company	0.35%	1,100,000	$15,829,000	—	31 Dec 2017	13F
PointState Capital LP	13F	Company	0.35%	1,085,900	$15,626,000	—	31 Dec 2017	13F
Artal Group S.A.	13F	Company	0.32%	1,000,000	$14,390,000	—	31 Dec 2017	13F
JPMORGAN CHASE & CO	13F	Company	0.32%	990,360	$14,251,000	—	31 Dec 2017	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.3%	950,313	$13,675,000	—	31 Dec 2017	13F
Rock Springs Capital Management LP	13F	Company	0.29%	910,000	$13,095,000	—	31 Dec 2017	13F
Bank of New York Mellon Corp	13F	Company	0.28%	879,535	$12,655,000	—	31 Dec 2017	13F
Allianz Asset Management GmbH	13F	Company	0.25%	791,260	$11,386,000	—	31 Dec 2017	13F
WELLS FARGO & COMPANY/MN	13F	Company	0.25%	771,905	$11,108,000	—	31 Dec 2017	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.24%	763,775	$10,991,000	—	31 Dec 2017	13F
CREDIT SUISSE AG/	13F	Company	0.22%	685,841	$9,870,000	—	31 Dec 2017	13F
MASSACHUSETTS FINANCIAL SERVICES CO /MA/	13F	Company	0.22%	685,115	$9,859,000	—	31 Dec 2017	13F
TEACHERS ADVISORS, LLC	13F	Company	0.21%	663,936	$9,554,000	—	31 Dec 2017	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.21%	652,017	$9,382,000	—	31 Dec 2017	13F
PRUDENTIAL FINANCIAL INC	13F	Company	0.19%	599,610	$8,797,000	—	31 Dec 2017	13F
Tekla Capital Management LLC	13F	Company	0.19%	604,920	$8,705,000	—	31 Dec 2017	13F
S.c.a. Candriam	13F	Individual	0.17%	540,400	$7,776,000	—	31 Dec 2017	13F
TIAA CREF INVESTMENT MANAGEMENT LLC	13F	Company	0.17%	529,668	$7,622,000	—	31 Dec 2017	13F

Institutional Holders of AMICUS THERAPEUTICS, INC. - Common Stock (FOLD) as of Q1 2018

As of 31 Mar 2018, AMICUS THERAPEUTICS, INC. - Common Stock (FOLD) was held by 198 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 224,632,187 shares. The largest 10 holders included PERCEPTIVE ADVISORS LLC, VANGUARD GROUP INC, BlackRock Inc., FMR LLC, Redmile Group, LLC, JENNISON ASSOCIATES LLC, venBio Select Advisor LLC, STATE STREET CORP, JANUS HENDERSON GROUP PLC, and WELLINGTON MANAGEMENT GROUP LLP. This page lists 198 institutional shareholders reporting positions in this security for the Q1 2018 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q1 2018 vs Q4 2017 Across Filers

Q4 2017 holders

181

Q1 2018 holders

198

Holder diff

Investor	Q4 2017 Shares	Q1 2018 Shares	Share Diff	Share Chg %	Q4 2017 Value $	Q1 2018 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.